The global market for Myocardial Infarction Device was valued at US$ 1024 million in the year 2024 and is projected to reach a revised size of US$ 1571 million by 2031, growing at a CAGR of 6.2% during the forecast period.

Myocardial Infarction Device Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Myocardial Infarction Device competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Myocardial infarction devices encompass medical instruments and technologies designed for the diagnosis, treatment, and monitoring of acute myocardial infarction (AMI). These include percutaneous coronary intervention (PCI) devices, cardiac pacemakers, ventricular assist devices, thrombus aspiration tools, and remote cardiac telemetry systems. They play a pivotal role in early detection, real-time intervention, and postoperative management of AMI patients, significantly enhancing survival rates and quality of life. With advancements in medical technology and the aging global population, the demand for myocardial infarction devices continues to rise, establishing them as a critical component in the cardiovascular treatment landscape. In 2024, global Myocardial Infarction Device production reached approximately 1.28 m units, with an average global market price of around US$ 800 perunit.

The escalating prevalence of cardiovascular diseases worldwide propels the demand for myocardial infarction treatment devices. Particularly in developing regions, improvements in healthcare infrastructure and heightened health awareness are prioritizing early diagnosis and intervention of AMI. Additionally, the aging population increases the number of high-risk individuals, further driving the need for advanced treatment devices. Technological innovations, such as biodegradable stents, remote cardiac monitoring, and AI-assisted diagnostic systems, enhance treatment efficacy and patient experience, serving as significant growth catalysts for the market.

Despite promising prospects, the myocardial infarction device industry faces several challenges. High research and development costs result in expensive devices, limiting accessibility in low-income regions. The technical complexity of these devices necessitates specialized training and maintenance, increasing operational costs for healthcare institutions. Furthermore, stringent global regulatory policies and complex approval processes may delay the introduction of new products to the market. Intense market competition and rapid technological advancements require continuous innovation to maintain a competitive edge.

Advancements in myocardial infarction treatment technologies have led to increased patient expectations regarding treatment outcomes and quality of life. Hospitals and healthcare providers are increasingly adopting efficient, low-risk treatment devices to enhance success rates and patient satisfaction. Additionally, there is a growing demand for remote monitoring and personalized treatment devices, driven by patients' heightened focus on postoperative rehabilitation and long-term health management. The aging population contributes to a rise in chronic cardiovascular disease patients, further boosting the demand for long-term treatment devices.

The primary raw materials for myocardial infarction treatment devices include high-performance metal alloys, biocompatible materials, sensor components, and integrated circuits. The quality of these materials directly impacts the device's performance and safety. Advancements in technology have led to increased demands for materials with enhanced properties, such as biodegradable materials and smart sensors, improving device functionality and patient comfort. However, ensuring a stable supply chain and controlling costs for these high-quality materials remain significant challenges for the industry.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Myocardial Infarction Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Myocardial Infarction Device.

The Myocardial Infarction Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Myocardial Infarction Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Myocardial Infarction Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Myocardial Infarction Device Market Report

Report Metric	Details
Report Name	Myocardial Infarction Device Market
Accounted market size in year	US$ 1024 million
Forecasted market size in 2031	US$ 1571 million
CAGR	6.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Coronary Stents Balloons Other
Segment by Application	Hospital Cardiac Cath Lab Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Abbott Laboratories, Johnson & Johnson, Boston Scientific, Medtronic, MicroPort Medical, Lepu Medical, Jiwei Medical, Sino Medical, Biotronik, Japan Lifeline, OSYPKA, CardioFocus
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Myocardial Infarction Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Myocardial Infarction Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Myocardial Infarction Device Market growing?

Ans: The Myocardial Infarction Device Market witnessing a CAGR of 6.2% during the forecast period 2025-2031.

What is the Myocardial Infarction Device Market size in 2031?

Ans: The Myocardial Infarction Device Market size in 2031 will be US$ 1571 million.

Who are the main players in the Myocardial Infarction Device Market report?

Ans: The main players in the Myocardial Infarction Device Market are Abbott Laboratories, Johnson & Johnson, Boston Scientific, Medtronic, MicroPort Medical, Lepu Medical, Jiwei Medical, Sino Medical, Biotronik, Japan Lifeline, OSYPKA, CardioFocus

What are the Application segmentation covered in the Myocardial Infarction Device Market report?

Ans: The Applications covered in the Myocardial Infarction Device Market report are Hospital, Cardiac Cath Lab, Other

What are the Type segmentation covered in the Myocardial Infarction Device Market report?

Ans: The Types covered in the Myocardial Infarction Device Market report are Coronary Stents, Balloons, Other

1 Myocardial Infarction Device Market Overview

1.1 Product Definition

1.2 Myocardial Infarction Device by Type

1.2.1 Global Myocardial Infarction Device Market Value Comparison by Type (2024 VS 2031)

1.2.2 Coronary Stents

1.2.3 Balloons

1.2.4 Other

1.3 Myocardial Infarction Device by Application

1.3.1 Global Myocardial Infarction Device Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Cardiac Cath Lab

1.3.4 Other

1.4 Global Myocardial Infarction Device Market Size Estimates and Forecasts

1.4.1 Global Myocardial Infarction Device Revenue 2020-2031

1.4.2 Global Myocardial Infarction Device Sales 2020-2031

1.4.3 Global Myocardial Infarction Device Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Myocardial Infarction Device Market Competition by Manufacturers

2.1 Global Myocardial Infarction Device Sales Market Share by Manufacturers (2020-2025)

2.2 Global Myocardial Infarction Device Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Myocardial Infarction Device Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Myocardial Infarction Device, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Myocardial Infarction Device, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Myocardial Infarction Device, Product Type & Application

2.7 Global Key Manufacturers of Myocardial Infarction Device, Date of Enter into This Industry

2.8 Global Myocardial Infarction Device Market Competitive Situation and Trends

2.8.1 Global Myocardial Infarction Device Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Myocardial Infarction Device Players Market Share by Revenue

2.8.3 Global Myocardial Infarction Device Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Myocardial Infarction Device Market Scenario by Region

3.1 Global Myocardial Infarction Device Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Myocardial Infarction Device Sales by Region: 2020-2031

3.2.1 Global Myocardial Infarction Device Sales by Region: 2020-2025

3.2.2 Global Myocardial Infarction Device Sales by Region: 2026-2031

3.3 Global Myocardial Infarction Device Revenue by Region: 2020-2031

3.3.1 Global Myocardial Infarction Device Revenue by Region: 2020-2025

3.3.2 Global Myocardial Infarction Device Revenue by Region: 2026-2031

3.4 North America Myocardial Infarction Device Market Facts & Figures by Country

3.4.1 North America Myocardial Infarction Device Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Myocardial Infarction Device Sales by Country (2020-2031)

3.4.3 North America Myocardial Infarction Device Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Myocardial Infarction Device Market Facts & Figures by Country

3.5.1 Europe Myocardial Infarction Device Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Myocardial Infarction Device Sales by Country (2020-2031)

3.5.3 Europe Myocardial Infarction Device Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Myocardial Infarction Device Market Facts & Figures by Region

3.6.1 Asia Pacific Myocardial Infarction Device Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Myocardial Infarction Device Sales by Region (2020-2031)

3.6.3 Asia Pacific Myocardial Infarction Device Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Myocardial Infarction Device Market Facts & Figures by Country

3.7.1 Latin America Myocardial Infarction Device Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Myocardial Infarction Device Sales by Country (2020-2031)

3.7.3 Latin America Myocardial Infarction Device Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Myocardial Infarction Device Market Facts & Figures by Country

3.8.1 Middle East and Africa Myocardial Infarction Device Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Myocardial Infarction Device Sales by Country (2020-2031)

3.8.3 Middle East and Africa Myocardial Infarction Device Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Myocardial Infarction Device Sales by Type (2020-2031)

4.1.1 Global Myocardial Infarction Device Sales by Type (2020-2025)

4.1.2 Global Myocardial Infarction Device Sales by Type (2026-2031)

4.1.3 Global Myocardial Infarction Device Sales Market Share by Type (2020-2031)

4.2 Global Myocardial Infarction Device Revenue by Type (2020-2031)

4.2.1 Global Myocardial Infarction Device Revenue by Type (2020-2025)

4.2.2 Global Myocardial Infarction Device Revenue by Type (2026-2031)

4.2.3 Global Myocardial Infarction Device Revenue Market Share by Type (2020-2031)

4.3 Global Myocardial Infarction Device Price by Type (2020-2031)

5 Segment by Application

5.1 Global Myocardial Infarction Device Sales by Application (2020-2031)

5.1.1 Global Myocardial Infarction Device Sales by Application (2020-2025)

5.1.2 Global Myocardial Infarction Device Sales by Application (2026-2031)

5.1.3 Global Myocardial Infarction Device Sales Market Share by Application (2020-2031)

5.2 Global Myocardial Infarction Device Revenue by Application (2020-2031)

5.2.1 Global Myocardial Infarction Device Revenue by Application (2020-2025)

5.2.2 Global Myocardial Infarction Device Revenue by Application (2026-2031)

5.2.3 Global Myocardial Infarction Device Revenue Market Share by Application (2020-2031)

5.3 Global Myocardial Infarction Device Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Abbott Laboratories

6.1.1 Abbott Laboratories Company Information

6.1.2 Abbott Laboratories Description and Business Overview

6.1.3 Abbott Laboratories Myocardial Infarction Device Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Abbott Laboratories Myocardial Infarction Device Product Portfolio

6.1.5 Abbott Laboratories Recent Developments/Updates

6.2 Johnson & Johnson

6.2.1 Johnson & Johnson Company Information

6.2.2 Johnson & Johnson Description and Business Overview

6.2.3 Johnson & Johnson Myocardial Infarction Device Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Johnson & Johnson Myocardial Infarction Device Product Portfolio

6.2.5 Johnson & Johnson Recent Developments/Updates

6.3 Boston Scientific

6.3.1 Boston Scientific Company Information

6.3.2 Boston Scientific Description and Business Overview

6.3.3 Boston Scientific Myocardial Infarction Device Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Boston Scientific Myocardial Infarction Device Product Portfolio

6.3.5 Boston Scientific Recent Developments/Updates

6.4 Medtronic

6.4.1 Medtronic Company Information

6.4.2 Medtronic Description and Business Overview

6.4.3 Medtronic Myocardial Infarction Device Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Medtronic Myocardial Infarction Device Product Portfolio

6.4.5 Medtronic Recent Developments/Updates

6.5 MicroPort Medical

6.5.1 MicroPort Medical Company Information

6.5.2 MicroPort Medical Description and Business Overview

6.5.3 MicroPort Medical Myocardial Infarction Device Sales, Revenue and Gross Margin (2020-2025)

6.5.4 MicroPort Medical Myocardial Infarction Device Product Portfolio

6.5.5 MicroPort Medical Recent Developments/Updates

6.6 Lepu Medical

6.6.1 Lepu Medical Company Information

6.6.2 Lepu Medical Description and Business Overview

6.6.3 Lepu Medical Myocardial Infarction Device Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Lepu Medical Myocardial Infarction Device Product Portfolio

6.6.5 Lepu Medical Recent Developments/Updates

6.7 Jiwei Medical

6.7.1 Jiwei Medical Company Information

6.7.2 Jiwei Medical Description and Business Overview

6.7.3 Jiwei Medical Myocardial Infarction Device Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Jiwei Medical Myocardial Infarction Device Product Portfolio

6.7.5 Jiwei Medical Recent Developments/Updates

6.8 Sino Medical

6.8.1 Sino Medical Company Information

6.8.2 Sino Medical Description and Business Overview

6.8.3 Sino Medical Myocardial Infarction Device Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Sino Medical Myocardial Infarction Device Product Portfolio

6.8.5 Sino Medical Recent Developments/Updates

6.9 Biotronik

6.9.1 Biotronik Company Information

6.9.2 Biotronik Description and Business Overview

6.9.3 Biotronik Myocardial Infarction Device Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Biotronik Myocardial Infarction Device Product Portfolio

6.9.5 Biotronik Recent Developments/Updates

6.10 Japan Lifeline

6.10.1 Japan Lifeline Company Information

6.10.2 Japan Lifeline Description and Business Overview

6.10.3 Japan Lifeline Myocardial Infarction Device Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Japan Lifeline Myocardial Infarction Device Product Portfolio

6.10.5 Japan Lifeline Recent Developments/Updates

6.11 OSYPKA

6.11.1 OSYPKA Company Information

6.11.2 OSYPKA Description and Business Overview

6.11.3 OSYPKA Myocardial Infarction Device Sales, Revenue and Gross Margin (2020-2025)

6.11.4 OSYPKA Myocardial Infarction Device Product Portfolio

6.11.5 OSYPKA Recent Developments/Updates

6.12 CardioFocus

6.12.1 CardioFocus Company Information

6.12.2 CardioFocus Description and Business Overview

6.12.3 CardioFocus Myocardial Infarction Device Sales, Revenue and Gross Margin (2020-2025)

6.12.4 CardioFocus Myocardial Infarction Device Product Portfolio

6.12.5 CardioFocus Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Myocardial Infarction Device Industry Chain Analysis

7.2 Myocardial Infarction Device Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Myocardial Infarction Device Production Mode & Process Analysis

7.4 Myocardial Infarction Device Sales and Marketing

7.4.1 Myocardial Infarction Device Sales Channels

7.4.2 Myocardial Infarction Device Distributors

7.5 Myocardial Infarction Device Customer Analysis

8 Myocardial Infarction Device Market Dynamics

8.1 Myocardial Infarction Device Industry Trends

8.2 Myocardial Infarction Device Market Drivers

8.3 Myocardial Infarction Device Market Challenges

8.4 Myocardial Infarction Device Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Myocardial Infarction Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Myocardial Infarction Device Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Myocardial Infarction Device Market Competitive Situation by Manufacturers in 2024

Table 4. Global Myocardial Infarction Device Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Myocardial Infarction Device Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Myocardial Infarction Device Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Myocardial Infarction Device Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Myocardial Infarction Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Myocardial Infarction Device, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Myocardial Infarction Device, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Myocardial Infarction Device, Product Type & Application

Table 12. Global Key Manufacturers of Myocardial Infarction Device, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Myocardial Infarction Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myocardial Infarction Device as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Myocardial Infarction Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Myocardial Infarction Device Sales by Region (2020-2025) & (K Units)

Table 18. Global Myocardial Infarction Device Sales Market Share by Region (2020-2025)

Table 19. Global Myocardial Infarction Device Sales by Region (2026-2031) & (K Units)

Table 20. Global Myocardial Infarction Device Sales Market Share by Region (2026-2031)

Table 21. Global Myocardial Infarction Device Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Myocardial Infarction Device Revenue Market Share by Region (2020-2025)

Table 23. Global Myocardial Infarction Device Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Myocardial Infarction Device Revenue Market Share by Region (2026-2031)

Table 25. North America Myocardial Infarction Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Myocardial Infarction Device Sales by Country (2020-2025) & (K Units)

Table 27. North America Myocardial Infarction Device Sales by Country (2026-2031) & (K Units)

Table 28. North America Myocardial Infarction Device Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Myocardial Infarction Device Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Myocardial Infarction Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Myocardial Infarction Device Sales by Country (2020-2025) & (K Units)

Table 32. Europe Myocardial Infarction Device Sales by Country (2026-2031) & (K Units)

Table 33. Europe Myocardial Infarction Device Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Myocardial Infarction Device Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Myocardial Infarction Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Myocardial Infarction Device Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Myocardial Infarction Device Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Myocardial Infarction Device Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Myocardial Infarction Device Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Myocardial Infarction Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Myocardial Infarction Device Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Myocardial Infarction Device Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Myocardial Infarction Device Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Myocardial Infarction Device Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Myocardial Infarction Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Myocardial Infarction Device Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Myocardial Infarction Device Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Myocardial Infarction Device Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Myocardial Infarction Device Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Myocardial Infarction Device Sales (K Units) by Type (2020-2025)

Table 51. Global Myocardial Infarction Device Sales (K Units) by Type (2026-2031)

Table 52. Global Myocardial Infarction Device Sales Market Share by Type (2020-2025)

Table 53. Global Myocardial Infarction Device Sales Market Share by Type (2026-2031)

Table 54. Global Myocardial Infarction Device Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Myocardial Infarction Device Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Myocardial Infarction Device Revenue Market Share by Type (2020-2025)

Table 57. Global Myocardial Infarction Device Revenue Market Share by Type (2026-2031)

Table 58. Global Myocardial Infarction Device Price (US$/Unit) by Type (2020-2025)

Table 59. Global Myocardial Infarction Device Price (US$/Unit) by Type (2026-2031)

Table 60. Global Myocardial Infarction Device Sales (K Units) by Application (2020-2025)

Table 61. Global Myocardial Infarction Device Sales (K Units) by Application (2026-2031)

Table 62. Global Myocardial Infarction Device Sales Market Share by Application (2020-2025)

Table 63. Global Myocardial Infarction Device Sales Market Share by Application (2026-2031)

Table 64. Global Myocardial Infarction Device Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Myocardial Infarction Device Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Myocardial Infarction Device Revenue Market Share by Application (2020-2025)

Table 67. Global Myocardial Infarction Device Revenue Market Share by Application (2026-2031)

Table 68. Global Myocardial Infarction Device Price (US$/Unit) by Application (2020-2025)

Table 69. Global Myocardial Infarction Device Price (US$/Unit) by Application (2026-2031)

Table 70. Abbott Laboratories Company Information

Table 71. Abbott Laboratories Description and Business Overview

Table 72. Abbott Laboratories Myocardial Infarction Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Abbott Laboratories Myocardial Infarction Device Product

Table 74. Abbott Laboratories Recent Developments/Updates

Table 75. Johnson & Johnson Company Information

Table 76. Johnson & Johnson Description and Business Overview

Table 77. Johnson & Johnson Myocardial Infarction Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Johnson & Johnson Myocardial Infarction Device Product

Table 79. Johnson & Johnson Recent Developments/Updates

Table 80. Boston Scientific Company Information

Table 81. Boston Scientific Description and Business Overview

Table 82. Boston Scientific Myocardial Infarction Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Boston Scientific Myocardial Infarction Device Product

Table 84. Boston Scientific Recent Developments/Updates

Table 85. Medtronic Company Information

Table 86. Medtronic Description and Business Overview

Table 87. Medtronic Myocardial Infarction Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Medtronic Myocardial Infarction Device Product

Table 89. Medtronic Recent Developments/Updates

Table 90. MicroPort Medical Company Information

Table 91. MicroPort Medical Description and Business Overview

Table 92. MicroPort Medical Myocardial Infarction Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. MicroPort Medical Myocardial Infarction Device Product

Table 94. MicroPort Medical Recent Developments/Updates

Table 95. Lepu Medical Company Information

Table 96. Lepu Medical Description and Business Overview

Table 97. Lepu Medical Myocardial Infarction Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Lepu Medical Myocardial Infarction Device Product

Table 99. Lepu Medical Recent Developments/Updates

Table 100. Jiwei Medical Company Information

Table 101. Jiwei Medical Description and Business Overview

Table 102. Jiwei Medical Myocardial Infarction Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Jiwei Medical Myocardial Infarction Device Product

Table 104. Jiwei Medical Recent Developments/Updates

Table 105. Sino Medical Company Information

Table 106. Sino Medical Description and Business Overview

Table 107. Sino Medical Myocardial Infarction Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Sino Medical Myocardial Infarction Device Product

Table 109. Sino Medical Recent Developments/Updates

Table 110. Biotronik Company Information

Table 111. Biotronik Description and Business Overview

Table 112. Biotronik Myocardial Infarction Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Biotronik Myocardial Infarction Device Product

Table 114. Biotronik Recent Developments/Updates

Table 115. Japan Lifeline Company Information

Table 116. Japan Lifeline Description and Business Overview

Table 117. Japan Lifeline Myocardial Infarction Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Japan Lifeline Myocardial Infarction Device Product

Table 119. Japan Lifeline Recent Developments/Updates

Table 120. OSYPKA Company Information

Table 121. OSYPKA Description and Business Overview

Table 122. OSYPKA Myocardial Infarction Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. OSYPKA Myocardial Infarction Device Product

Table 124. OSYPKA Recent Developments/Updates

Table 125. CardioFocus Company Information

Table 126. CardioFocus Description and Business Overview

Table 127. CardioFocus Myocardial Infarction Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. CardioFocus Myocardial Infarction Device Product

Table 129. CardioFocus Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Myocardial Infarction Device Distributors List

Table 133. Myocardial Infarction Device Customers List

Table 134. Myocardial Infarction Device Market Trends

Table 135. Myocardial Infarction Device Market Drivers

Table 136. Myocardial Infarction Device Market Challenges

Table 137. Myocardial Infarction Device Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Product Picture of Myocardial Infarction Device

Figure 2. Global Myocardial Infarction Device Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Myocardial Infarction Device Market Share by Type: 2024 & 2031

Figure 4. Coronary Stents Product Picture

Figure 5. Balloons Product Picture

Figure 6. Other Product Picture

Figure 7. Global Myocardial Infarction Device Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Myocardial Infarction Device Market Share by Application: 2024 & 2031

Figure 9. Hospital

Figure 10. Cardiac Cath Lab

Figure 11. Other

Figure 12. Global Myocardial Infarction Device Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Myocardial Infarction Device Market Size (2020-2031) & (US$ Million)

Figure 14. Global Myocardial Infarction Device Sales (2020-2031) & (K Units)

Figure 15. Global Myocardial Infarction Device Average Price (US$/Unit) & (2020-2031)

Figure 16. Myocardial Infarction Device Report Years Considered

Figure 17. Myocardial Infarction Device Sales Share by Manufacturers in 2024

Figure 18. Global Myocardial Infarction Device Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Myocardial Infarction Device Players: Market Share by Revenue in Myocardial Infarction Device in 2024

Figure 20. Myocardial Infarction Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Myocardial Infarction Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Myocardial Infarction Device Sales Market Share by Country (2020-2031)

Figure 23. North America Myocardial Infarction Device Revenue Market Share by Country (2020-2031)

Figure 24. United States Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Myocardial Infarction Device Sales Market Share by Country (2020-2031)

Figure 27. Europe Myocardial Infarction Device Revenue Market Share by Country (2020-2031)

Figure 28. Germany Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Myocardial Infarction Device Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Myocardial Infarction Device Revenue Market Share by Region (2020-2031)

Figure 35. China Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Myocardial Infarction Device Sales Market Share by Country (2020-2031)

Figure 43. Latin America Myocardial Infarction Device Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Myocardial Infarction Device Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Myocardial Infarction Device Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Myocardial Infarction Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Myocardial Infarction Device by Type (2020-2031)

Figure 54. Global Revenue Market Share of Myocardial Infarction Device by Type (2020-2031)

Figure 55. Global Myocardial Infarction Device Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Myocardial Infarction Device by Application (2020-2031)

Figure 57. Global Revenue Market Share of Myocardial Infarction Device by Application (2020-2031)

Figure 58. Global Myocardial Infarction Device Price (US$/Unit) by Application (2020-2031)

Figure 59. Myocardial Infarction Device Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Adult Artificial Heart Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32W16534

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Cardioplegia Adapter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33A16598

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Inotropic Drug Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23Y16200

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Retrograde Cardioplegia Cannula Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29Z16493

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions